Silver Book Fact

Fact image

Annual Total Burden to the U.S. Economy of AMD, Cararact, Diabetic Retinopathy, Glaucoma, Refractive Errors, Visual Impairment and Blindness

Rein D, Zhang P, Wirth K, Lee P, et al. The Economic Burden of Major Adult Visual Disorders in the United States. Arch Opthalmol. 2006; 124(12): 1754-60. http://archopht.ama-assn.org/cgi/content/abstract/124/12/1754

Reference

Title
The Economic Burden of Major Adult Visual Disorders in the United States
Publication
Arch Opthalmol
Publication Date
2006
Authors
Rein D, Zhang P, Wirth K, Lee P, et al
Volume & Issue
Volume 124, Issue 12
Pages
1754-60
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Around 711,000 Americans age 80 and older have glaucoma– 7.7% of the 80 and older population.  
  • Expenditures for glaucoma medications are on the rise–mean annual glaucoma medication expenditures per indiviual increased from $445 in 2001 to $557 in 2006.  
  • Increase in trouble seeing with age, 2010
    10.3% of the non-institutionalized adults 65 years and older have some trouble seeing, even with glasses or contacts.  That number increases to 16.5% in adults 75 years and older.  
  • The number of cases of visual impairment and blindness from age-related macular degeneration (AMD0 is projected to increase from 620,000 in 2010 to 1.6 million in 2050–assuming no treatments.  
  • The average cost in 2004 per glaucoma patient age 40 to 64 using outpatient services was $276. The average cost per patient 54 years and older was $254.